- Home
- IMCR vs TBBK Comparison
IMCR vs TBBK Comparison
Compare IMCR & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- TBBK
- Stock Information
- Founded
- IMCR 2008
- TBBK 1999
- Country
- IMCR United Kingdom
- TBBK United States
- Employees
- IMCR N/A
- TBBK N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- TBBK Major Banks
- Sector
- IMCR Health Care
- TBBK Finance
- Exchange
- IMCR Nasdaq
- TBBK Nasdaq
- Market Cap
- IMCR 1.7B
- TBBK 2.7B
- IPO Year
- IMCR 2021
- TBBK 2004
- Fundamental
- Price
- IMCR $32.93
- TBBK $50.58
- Analyst Decision
- IMCR Buy
- TBBK Buy
- Analyst Count
- IMCR 14
- TBBK 3
- Target Price
- IMCR $74.75
- TBBK $55.00
- AVG Volume (30 Days)
- IMCR 267.8K
- TBBK 564.7K
- Earning Date
- IMCR 11-05-2024
- TBBK 10-24-2024
- Dividend Yield
- IMCR N/A
- TBBK N/A
- EPS Growth
- IMCR N/A
- TBBK 16.52
- EPS
- IMCR N/A
- TBBK 3.95
- Revenue
- IMCR $280,914,000.00
- TBBK $472,015,000.00
- Revenue This Year
- IMCR $25.60
- TBBK N/A
- Revenue Next Year
- IMCR $10.63
- TBBK $7.05
- P/E Ratio
- IMCR N/A
- TBBK $12.71
- Revenue Growth
- IMCR 27.95
- TBBK 6.71
- 52 Week Low
- IMCR $29.72
- TBBK $29.92
- 52 Week High
- IMCR $76.98
- TBBK $59.26
- Technical
- Relative Strength Index (RSI)
- IMCR 52.76
- TBBK 44.27
- Support Level
- IMCR $31.10
- TBBK $45.82
- Resistance Level
- IMCR $35.47
- TBBK $59.26
- Average True Range (ATR)
- IMCR 1.49
- TBBK 2.17
- MACD
- IMCR 0.17
- TBBK -0.96
- Stochastic Oscillator
- IMCR 51.98
- TBBK 35.86
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.